Holen Sie sich die Stockscreener-App
210.06
3.41%
6.93
Vorhandelsmarkt:
209.52
-0.54
-0.26%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$203.13
Offen:
$207.5
24-Stunden-Volumen:
6.83M
Relative Volume:
1.19
Marktkapitalisierung:
$330.21B
Einnahmen:
$128.77B
Nettoeinkommen (Verlust:
$20.37B
KGV:
16.98
EPS:
12.3718
Netto-Cashflow:
$39.02B
1W Leistung:
-2.38%
1M Leistung:
-0.78%
6M Leistung:
+14.91%
1J Leistung:
+44.93%
1-Tages-Spanne:
$205.30
$211.15
1-Wochen-Bereich:
$202.94
$219.40
52-Wochen-Spanne:
$136.17
$232.25
Morgan Stanley Stock (MS) Company Profile
Firmenname
Morgan Stanley
Sektor
Branche
Telefon
212-761-4000
Adresse
1585 BROADWAY, NEW YORK, NY
Compare MS vs GS, SCHW, HOOD, IBKR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
210.06 | 337.29B | 128.77B | 20.37B | 39.02B | 12.37 |
GS
Goldman Sachs Group Inc
|
1,024.86 | 309.24B | 128.57B | 20.97B | 112.72B | 64.79 |
SCHW
Charles Schwab Corp
|
104.33 | 181.18B | 28.33B | 9.42B | 9.76B | 5.0426 |
HOOD
Robinhood Markets Inc
|
86.60 | 85.87B | 4.65B | 1.89B | -2.09B | 2.0676 |
IBKR
Interactive Brokers Group Inc
|
90.48 | 41.10B | 10.76B | 4.56B | 35.82B | 2.326 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-06-30 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2026-04-27 | Hochstufung | Erste Group | Hold → Buy |
| 2026-04-07 | Hochstufung | UBS | Neutral → Buy |
| 2026-03-05 | Herabstufung | Erste Group | Buy → Hold |
| 2025-11-24 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-07-09 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-11-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-09-11 | Herabstufung | Goldman | Buy → Neutral |
| 2024-08-02 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-07-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-01-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-01-17 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-09 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-11-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-11-20 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2023-10-23 | Herabstufung | Odeon | Buy → Hold |
| 2023-10-20 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2023-10-11 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-07 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-12 | Hochstufung | Odeon | Hold → Buy |
| 2023-01-18 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-10 | Hochstufung | Odeon | Sell → Hold |
| 2023-01-04 | Herabstufung | Wolfe Research | Outperform → Underperform |
| 2022-10-05 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-09-06 | Herabstufung | Odeon | Hold → Sell |
| 2022-05-03 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-01-28 | Herabstufung | Odeon | Buy → Hold |
| 2021-12-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-10-04 | Bestätigt | Jefferies | Buy |
| 2021-09-29 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-09-28 | Herabstufung | Berenberg | Buy → Hold |
| 2021-08-13 | Herabstufung | Seaport Global Securities | Buy → Neutral |
| 2021-07-07 | Fortgesetzt | Keefe Bruyette | Outperform |
| 2021-06-09 | Eingeleitet | Jefferies | Buy |
| 2021-04-21 | Hochstufung | Berenberg | Hold → Buy |
| 2021-03-02 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2021-01-06 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-01-04 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-11-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-10-13 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-08 | Eingeleitet | Seaport Global Securities | Buy |
| 2020-06-24 | Hochstufung | DA Davidson | Neutral → Buy |
| 2020-06-23 | Bestätigt | UBS | Buy |
| 2020-05-21 | Hochstufung | Odeon | Hold → Buy |
| 2020-04-14 | Hochstufung | Societe Generale | Sell → Buy |
| 2020-03-13 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-21 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-02-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-01-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-01-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-01-09 | Eingeleitet | DA Davidson | Buy |
| 2020-01-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-29 | Herabstufung | Odeon | Buy → Hold |
| 2019-10-10 | Hochstufung | Sandler O'Neill | Hold → Buy |
| 2019-07-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-04-18 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Morgan Stanley Aktie (MS) Neueste Nachrichten
Morgan Stanley launches ETH, Solana ETFs at 0.14% - Crypto News
Morgan Stanley Launches 0.14% Ethereum and Solana ETFs: Will Flows Follow? - BeInCrypto
Philadelphia Semiconductor Index Falls Over 5% and SanDisk Drops Over 15% as Software Stocks Buck Trend After Morgan Stanley Says They Are Oversold - TradingKey
Morgan Stanley Debuts Lowest-Cost Ethereum, Solana ETFsMorgan Stanley Ethereum Trust (ARCA:MSSE), Morg - Benzinga
F5 Fiscal Q3 Exceeded Expectations on Systems, Gross Margin Upside, Morgan Stanley Says - marketscreener.com
Morgan Stanley rolls out new crypto funds that reward you for holding - thestreet.com
Morgan Stanley launches low-cost ether and sola... - Pluang
Morgan Stanley expands ETP line with Ethereum, Solana products (MS:NYSE) - Seeking Alpha
Morgan Stanley launches low-fee Ethereum and So... - Pluang
MU, AMD, INTC, SNDK Stocks Fall — Morgan Stanley's Mike Wilson Explains Why Investors Are Going After Chip And Memory Stocks - Yahoo Finance
Morgan Stanley Launches Ethereum and Solana ETFs Following NYSE Arca Approval - CoinGape
Morgan Stanley Investment Management Selects Figment as a Staking Provider for Its New Ether and SOL ETPs - Business Wire
Morgan Stanley debuts ether, solana exchange-traded products after bitcoin fund success - CoinDesk
Morgan Stanley debuts Ethereum and Solana ETFs with market's lowest fee, staking rewards - The Block
Morgan Stanley launches low-cost Ethereum and S... - Pluang
Citi hires Morgan Stanley veteran Rob Lunn as it ramps up investment management - InvestmentNews
Veolia slips, Morgan Stanley sees limited upside potential - marketscreener.com
Morgan Stanley Expands Crypto ETF Suite With New Ethereum & Solana Trusts - ETF Trends
Morgan Stanley Investment Management Expands ETP Offerings With Launch of Ethereum and Solana Exchange-Traded Products - Carroll County Mirror-Democrat
Morgan Stanley Backs This Stock on Improving Growth, Margin Recovery By Investing.com - Investing.com Canada
Morgan Stanley Reaffirms "Equal Weight" Rating for Maplight Therapeutics (NASDAQ:MPLT) - MarketBeat
Morgan Stanley Estimates GenAI ROIC at 25%-50%, Providing Strong Backing for Inference-Era Capex Logic - finance.biggo.com
The numbers add up! Morgan Stanley: In the age of reasoning, generative AI could deliver a return on capital of 25–50%. - Moomoo
Morgan Stanley raises Corpay stock price target on growth outlook - Investing.com
Morgan Stanley raises Datadog stock price target on growth momentum - Investing.com
Morgan Stanley Adjusts Price Target on Datadog to $300 From $225, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Downgrades MapLight Therapeutics to Equalweight From Overweight, $34 PT - marketscreener.com
Morgan Stanley Adjusts PT on Cadence Design Systems to $400 From $370, Maintains Overweight Rating - marketscreener.com
Morgan Stanley's Mike Wilson: Still very constructive on where the S&P 500 ends up for the full year - CNBC
Morgan Stanley says SpaceX at $100 would imply zero AI value after stock plunges roughly 50% from post-IPO high - Yahoo! Finance Canada
Investors expect SpaceX to slide to $100 per share which suggests zero AI business value - moneywise.com
Morgan Stanley leads construction M&A advisory in H1 2026 - World Construction Network
Morgan Stanley Adjusts Price Target on Corpay to $415 From $400, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on F5 to $415 From $380, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Navitas Semiconductor to $12.60 From $13.70, Keeps Underweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Amkor Technology to $70 From $69, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley says load up on these 13 AI power infrastructure stocks — including 2 'standout' energy storage plays - Business Insider
Conversica Receives Investment From Morgan Stanley Expansion Capital - FinSMEs
REGIntnl Personal Fin Morgan StanleyHolding(s) in Company - TradingView
SpaceX selloff implies zero value for AI business: Morgan Stanley - ETEnterpriseai.com
Strong earnings, record highs – so why is Wall Street stuck? - The Australian
France analyst views: LVMH gets tongues wagging, Morgan Stanley downgrades Veolia - marketscreener.com
Morgan Stanley Names Top Picks in Japan’s Space Sector - Investing.com
Morgan Stanley raises SSAB price target to 115 kronor (100), reiterates overweightBN - marketscreener.com
Morgan Stanley rates TCL as Equal-weight - marketscreener.com
‘Don’t Get Too Excited,’ Says Morgan Stanley About Applied Digital Stock - TipRanks
Morgan Stanley sees a troubling S&P 500 repeat - thestreet.com
AI Adopters Could Boost Net Margins by One Percentage Point by 2027, Morgan Stanley Says - Briefs Finance
Morgan Stanley downgrades MapLight Therapeutics stock rating on trial results - Investing.com Canada
Morgan Stanley raises Nurix stock price target on growth potential - Investing.com
Morgan Stanley raises Nurix stock price target on growth potential By Investing.com - Investing.com Canada
Finanzdaten der Morgan Stanley-Aktie (MS)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.50%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):